Trial Profile
A phase I trial of WT-induced adoptive T cell therapy in solid tumors
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 16 Nov 2017
Price :
$35
*
At a glance
- Drugs WT-induced adoptive T cell therapy - Eutilex (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Eutilex
- 16 Nov 2017 New trial record